Skip to main content
. 2017 Feb 1;8(12):19699–19711. doi: 10.18632/oncotarget.14963

Table 2. The levels of serum leptin in the each primary study.

Author Year Cases Controls Unit Method Study Quality Score
Mean SD1 N Mean SD N
Aleman MR 2002 7.11 0.91 76 18.50 4.17 30 ng/ml RIA2 7
Carpagnano GE 2007 45.3 19.9 32 22.7 0.4 20 ng/ml ELISA3 7
Dong JH 2009 8.67 2.28 64 5.75 1.70 70 ng/ml ELISA 7
Hong X 2013 6.45 2.55 41 7.05 2.61 51 ng/ml ELISA 7
Jamieson NB 2004 6.7 11.85 20 15.8 9.1 13 ng/ml ELISA 7
Kerenidi T 2013 3.87 8.80 80 10.76 8.42 40 ng/ml RIA 7
Luo NP 2008 5.72 1.16 42 4.18 0.51 30 ng/ml RIA 6
Mou WJ 2014 3.78 3.30 27 1.73 0.94 27 ng/ml RIA 8
Song CH 2014 9.66 5.73 126 4.75 2.98 60 ng/ml ELISA 7
Tao XN 2003 1.50 0.80 34 3.20 1.80 25 ng/ml RIA 6
Tas F 2005 6.2 44.5 28 12.5 6.88 15 ng/ml ELISA 5
Terzidis A 2009 9.30 9.20 66 7.1 5.8 132 ng/ml RIA 7
Werynska B 2009 9.0 8.85 40 10 7.6 15 ng/ml ELISA 6
Zhang ZH 2003 6.81 6.3 97 6.44 4.59 66 ng/ml RIA 5
Cases with Weight Loss Cases without Weight Loss
Hong X 2013 5.12 1.38 15 7.22 2.76 26 ng/ml ELISA 7
Werynska B 2009 6.0 7.8 20 12 9 20 ng/ml ELISA 6

1: standard deviation; 2: radioimmunoassay; 3: enzyme-linked immunosorbent assay